The FDA’s Experience with Emerging Genomics Technologies—Past, Present, and Future
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science
Link
http://link.springer.com/article/10.1208/s12248-016-9917-y/fulltext.html
Reference31 articles.
1. Goodsaid FM, Amur S, Aubrecht J, Burczynski ME, Carl K, Catalano J, et al. Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact. Nat Rev Drug Discov. 2010;9(6):435–45. doi: 10.1038/nrd3116 .
2. Tong W, Harris SC, Fang H, Shi L, Perkins R, Goodsaid F, et al. An integrated bioinformatics infrastructure essential for advancing pharmacogenomics and personalized medicine in the context of the FDA’s critical path initiative. Drug Discov Today Technol. 2007;4(1):3–8. doi: 10.1016/j.ddtec.2007.10.008 .
3. Tong W, Ostroff S, Blais B, Silva P, Dubuc M, Healy M, et al. Genomics in the land of regulatory science. Regul Toxicol Pharmacol. 2015;72(1):102–6. doi: 10.1016/j.yrtph.2015.03.008 .
4. Shi L, Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol. 2010;28(8):827–38. doi: 10.1038/nbt.1665 .
5. Chierici M, Miclaus K, Vega S, Furlanello C. An interactive effect of batch size and composition contributes to discordant results in GWAS with the CHIAMO genotyping algorithm. Pharmacogenomics J. 2010;10(4):355–63. doi: 10.1038/tpj.2010.47 .
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Using synthetic chromosome controls to evaluate the sequencing of difficult regions within the human genome;Genome Biology;2022-01-12
2. Toxicogenomics: A Primer for Toxicologic Pathologists;Haschek and Rousseaux's Handbook of Toxicologic Pathology;2022
3. The Sequencing Quality Control 2 study: establishing community standards for sequencing in precision medicine;Genome Biology;2021-11-08
4. Integration of OMICS Technologies for Crop Improvement;Protein & Peptide Letters;2021-09-10
5. Transcriptome from opaque cornea of Fanconi anemia patient uncovers fibrosis and two connected players;Molecular Genetics and Metabolism Reports;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3